Dr. Korthuis is a practicing general internist, addiction medicine provider, and clinician scientist. He began his clinical career treating patients living with HIV and became board-certified in addiction medicine in 2010. His research focuses on improving integration of addiction treatment in diverse health care settings, including HIV clinics. He serves as Principal Investigator for two international trials funded by the National Institute on Drug Abuse: The CTN-0055/0067 CHOICES trial of clinic-based extended-release naltrexone in North American HIV clinics, and the BRAVO trial of clinic-based buprenorphine for opioid use disorder in Vietnam HIV clinics. He is co-investigator in the National Institute of Drug Abuse Clinical Trials Network Western States Node, collaborating in clinical trials of opioid, methamphetamine, and cocaine treatment. Honors include the 2008 Lawrence S. Linn Award for research that improves the lives of people living with HIV and a 2012-2013 Fulbright Scholar award to study integration of HIV and addiction care in Vietnam. Dr. Korthuis serves as Program Director for the OHSU Addiction Medicine Fellowship and Co-Director of the Oregon Addiction Education and Prevention Initiative that provides training and support for rural primary care providers in pharmacotherapy for substance use disorders.
- M.P.H., University of California at Los Angeles, Los Angeles California 0
- M.D., University of Health Sciences, Chicago Medical School, Chicago Illinois 0 1997
- Internal medicine, Yale University School of Medicine
- Health services research, VA Ambulatory Care/UCLA Fellowship
- Internal medicine
Memberships and associations
- Society of General Internal Medicine